Preterm birth reduces the incidence of atopy in adulthood

Mirjami Siltanen1, Karoliina Wehkalampi, Petteri Hovi

  • 1Division of Welfare and Health Promotion, Department of Chronic Disease Prevention, Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.

Insights

Young adults born very preterm have a reduced risk of atopy, suggesting early development influences lifelong allergic disease. This study investigated preterm birth and atopy in young adulthood.

Area of Science:

  • Immunology and developmental biology
  • Allergy and immunology research
  • Perinatal and neonatal studies

Background:

  • Early-life immunologic pathways are crucial for lifelong health.
  • Preterm birth may alter immune development, influencing atopy risk.
  • Previous research on preterm birth and adult atopy is inconclusive.

Purpose of the Study:

  • To compare atopy incidence in young adults born preterm with very low birth weight (VLBW) to term-born controls.
  • To assess atopic predisposition using skin prick tests and IgE levels.

Main Methods:

  • Study included 166 VLBW preterm adults and 172 term-born controls.
  • Atopy assessed via skin prick tests (6 aeroallergens) and serum IgE (total and specific).
  • Logistic/linear regression adjusted for confounding factors; self-reported diagnoses of asthma, allergic rhinitis, and atopic eczema were analyzed.

Main Results:

  • Reduced risk of positive skin prick tests in VLBW preterm adults (aOR 0.43).
  • Lower cat-specific IgE concentrations observed in VLBW preterm adults.
  • Earlier gestational age at birth correlated with lower atopy risk within the VLBW group.

Conclusions:

  • Young adults born preterm with VLBW exhibit lower atopy incidence than term-born individuals.
  • Findings support the hypothesis that early developmental stages significantly determine atopy risk.
  • Atopic disease incidence was similar between VLBW adults and controls.
Abstract

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311